Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 48 out of 100. Mild cognitive impairment

Topic: Risk, prevention and care in population studies

Plain-language summary

= 0.005). Cox regression analysis revealed that polypharmacy was significantly associated with a reduced risk of MCI progression to dementia (hazard ratio [HR] = 0.49, 95% confidence interval [CI]: 0.31 to 0.78) after adjusting for covariates. Medication counts ranging from ≥5 to ≥8 were significantly associated with a reduced dementia risk, without a clear cut-off. Further analysis suggested that antihypertensive and lipid-modifying drugs were associated with a reduced risk of dementia progression. Our findings suggest that polypharmacy is associated with a lower risk of progression to dementia in people with MCI, highlighting the importance of medication appropriateness over medication count. Future research should optimize pharmacological strategies to balance the risks and benefits of polypharmacy in older adults with MCI. Highlights: Polypharmacy was linked to reduced dementia risk in older adults with MCI.No clear medication threshold (≥5 to ≥8) for dementia risk reduction was found.Specific medications were associated with a lower risk of dementia progression.The importance of medication purpose and type over medication count is highlighted.Future studies should optimize pharmacological strategies in older adults with MCI.

What this study adds

Evidence grade: Moderate

This is a follow-up (cohort) study. Polypharmacy was associated with a reduced risk of progression from mild cognitive impairment to dementia, and antihypertensive and lipid-modifying drugs were also linked to reduced risk. The authors note the importance of medication appropriateness over medication count, and this is an observational association that does not establish that any medication prevents dementia.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Hsu, Y., Liang, C., Chou, M.-Y., Shen, H., Wang, Y., Iwaki, H., et al. (2025). Polypharmacy and risk of dementia progression in older adults with mild cognitive impairment: A longitudinal cohort study. Alzheimer s & Dementia Translational Research & Clinical Interventions. https://doi.org/10.1002/trc2.70179

Vancouver

Hsu Y, Liang C, Chou M.-Y, Shen H, Wang Y, Iwaki H, et al. Polypharmacy and risk of dementia progression in older adults with mild cognitive impairment: A longitudinal cohort study. Alzheimer s & Dementia Translational Research & Clinical Interventions. 2025. doi:10.1002/trc2.70179. PMID: 41268047.

BibTeX

@article{hsu2025-41268047,
  author  = {Hsu, Ying‐Hsin and Liang, Chih‐Kuang and Chou, Ming-Yueh and Shen, Hsiu‐Chu and Wang, Yu‐Chun and Iwaki, Hirotaka and Lin, Yu‐Te and Fann, Yang Cheng},
  title   = {{Polypharmacy and risk of dementia progression in older adults with mild cognitive impairment: A longitudinal cohort study}},
  journal = {Alzheimer s \& Dementia Translational Research \& Clinical Interventions},
  year    = {2025},
  doi     = {10.1002/trc2.70179},
  pmid    = {41268047},
  url     = {https://doi.org/10.1002/trc2.70179}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.

Key findings

Why it matters

Polypharmacy was associated with a reduced risk of progression from mild cognitive impairment to dementia, and antihypertensive and lipid-modifying drugs were also linked to reduced risk. The authors note the importance of medication appropriateness over medication count, and this is an observational association that does not establish that any medication prevents dementia.

Study details

How this study scored 48/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 1 of 4; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 1 of 5; Impact for its field and year 2 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record 2 of 4; Institution's track record 3 of 3; Multicenter collaboration 2 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 48 of 100.48 of 100 points earned52 not earned

Published in a peer-reviewed journal, and it is a cohort study following people over time. Scored zero for sample size, effect reported, studied in people and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Alzheimer s & Dementia Translational Research & Clinical Interventions)
Journal's citation record 1 / 4 Alzheimer s & Dementia Translational Research & Clinical Interventions: journal h-index 84 (OpenAlex, 2026-10-29)
Study design 7 / 12 A cohort study following people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 4 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 1.3 citations a year over 3 year(s) since 2025
Impact for its field and year 2 / 6 Cited 2.1× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 4 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Yang Cheng Fann: h-index 23 (OpenAlex, whole career)
Institution's track record 3 / 3 National Institutes of Health: institution h-index 2,723 (OpenAlex)
Multicenter collaboration 2 / 3 OpenAlex lists 9 institution(s) in 2 countries
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41268047)
Free to read 2 / 2 Free to read
Total 48 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Mild cognitive impairment from nearby years

Also tagged “biobank”

1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Mild cognitive impairment

See all studies in Mild cognitive impairment →